(Total Views: 53)
Posted On: 03/30/2021 10:42:47 AM
Post# of 17891

$CURR CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline
https://finance.yahoo.com/news/cure-pharmaceu...00116.html
https://finance.yahoo.com/news/cure-pharmaceu...00116.html

